Related Experiment Video
Updated: Jan 18, 2026

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
Endoplasmic Reticulum Stress Inhibition Promotes Mitophagy via Miro1 Reduction to Rescue Mitochondrial Dysfunction
Yuqi Wen1, Zheng Han1,2, Bao Wang1,3
1Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, 569 Xinsi Road, Xi'an, 710038, Shaanxi, China.
Abstract:
Both mitochondrial dysfunction and endoplasmic reticulum stress (ERS) have been implicated in the pathogenesis of Parkinson's disease (PD). However, the underlying regulatory mechanisms between ERS and mitochondrial dysfunction remain unclear. In the present study, we found that an in vitro model of Parkinson's disease (PD) induced by methyl-4-phenylpyridine (MPP+) showed increased intracellular peroxidation, leading to a significant increase in ERS. ER staining and immunofluorescence analysis of ERS-related proteins verified the presence of ERS, whereas transmission electron microscopy (TEM) showed complete depletion of ER. Notably, treatment with 4-phenylbutyric acid (4-PBA) to suppress ERS reduced apoptosis and concurrently reversed the ER micromorphology. Furthermore, 4-PBA alleviated mitochondrial dysfunction, as shown by increased mitochondrial membrane potential (MMP), upregulation of electron transport chain proteins, and restoration of mitochondrial integrity. Further studies revealed that the effect of 4-PBA could be attributed to the modulation of the mitochondrial Rho-GTPase 1 (Miro1)-mitophagy axis. In vivo experiments in Parkinson's disease models demonstrated that inhibiting ERS reduced dopaminergic neuron loss while improving cognitive and motor function. Collectively, these findings indicate that treatments targeting ERS may be potential candidates for treating PD.
Insights
Endoplasmic reticulum stress (ERS) contributes to Parkinson's disease (PD) pathogenesis by impairing mitochondria. Suppressing ERS with 4-phenylbutyric acid (4-PBA) protects neurons and improves motor function in PD models.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Mitochondrial dysfunction and endoplasmic reticulum stress (ERS) are implicated in Parkinson's disease (PD) pathogenesis.
- The precise regulatory mechanisms linking ERS and mitochondrial dysfunction in PD remain elusive.
Purpose of the Study:
- To investigate the relationship between ERS and mitochondrial dysfunction in a Parkinson's disease model.
- To evaluate the therapeutic potential of targeting ERS in PD.
Main Methods:
- Utilized an in vitro Parkinson's disease model induced by methyl-4-phenylpyridine (MPP+).
- Assessed ERS using ER staining and immunofluorescence for ERS-related proteins.
- Examined ER morphology via transmission electron microscopy (TEM).
- Investigated the effects of 4-phenylbutyric acid (4-PBA) on apoptosis, ER morphology, mitochondrial function, and the Miro1-mitophagy axis.
- Conducted in vivo experiments in PD models.
Main Results:
- MPP+-induced PD models exhibited increased intracellular peroxidation and significant ERS with ER depletion.
- 4-PBA treatment suppressed ERS, reduced apoptosis, and restored ER micromorphology.
- 4-PBA alleviated mitochondrial dysfunction, evidenced by increased mitochondrial membrane potential (MMP), upregulated electron transport chain proteins, and restored mitochondrial integrity.
- The therapeutic effects of 4-PBA were linked to modulation of the Miro1-mitophagy axis.
- Inhibition of ERS in vivo reduced dopaminergic neuron loss and improved cognitive and motor functions.
Conclusions:
- ERS plays a critical role in the pathogenesis of Parkinson's disease.
- Targeting ERS, for example, with 4-PBA, offers a promising therapeutic strategy for PD by mitigating mitochondrial dysfunction and neurodegeneration.
More Related Videos
15:09The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
06:57Author Spotlight: Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells
Published on: May 12, 2023
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Export of Misfolded Proteins out of the ER
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitochondrial Membranes